Berenberg Bank Reiterates “€26.50” Price Target for Rhoen Klinikum AG (ETR:RHK)
Several other brokerages have also recently issued reports on RHK. Deutsche Bank AG set a €21.00 ($24.71) price objective on Rhoen Klinikum AG and gave the stock a neutral rating in a research note on Wednesday, July 26th. Jefferies Group LLC set a €17.60 ($20.71) price objective on Rhoen Klinikum AG and gave the stock a sell rating in a research note on Thursday, August 3rd. Commerzbank Ag set a €25.00 ($29.41) price objective on Rhoen Klinikum AG and gave the stock a neutral rating in a research note on Tuesday, July 25th. DZ Bank AG restated a sell rating on shares of Rhoen Klinikum AG in a research note on Monday, May 29th. Finally, Credit Suisse Group set a €24.40 ($28.71) price objective on Rhoen Klinikum AG and gave the stock a sell rating in a research note on Friday. Three investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The company presently has a consensus rating of Hold and an average price target of €23.50 ($27.65).
Rhoen Klinikum AG (ETR RHK) traded up 0.296% during midday trading on Monday, hitting €26.771. The company’s stock had a trading volume of 100 shares. The company’s 50-day moving average is €25.99 and its 200 day moving average is €25.81. Rhoen Klinikum AG has a one year low of €22.91 and a one year high of €27.51. The company has a market cap of €1.79 billion and a price-to-earnings ratio of 125.098.
COPYRIGHT VIOLATION NOTICE: This report was first published by Daily Political and is the property of of Daily Political. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.dailypolitical.com/2017/08/08/berenberg-bank-reiterates-26-50-price-target-for-rhoen-klinikum-ag-etrrhk.html.
Rhoen Klinikum AG Company Profile
Receive News & Ratings for Rhoen Klinikum AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum AG and related companies with MarketBeat.com's FREE daily email newsletter.